Skip to content

Our Work

HIV Prevention

Studies include:

  • Phase 3 efficacy trial of monthly oral PrEP in African women (EXPrESSIVE-10), in partnership with Merck, MSD, and Gates Foundation (EXPrESSIVE Study, Celum, PI)
  • Adherence efficacy relationships for tenofovir-based PrEP in African women; (Benchmark study, Mugwanya, PI)

Read more

Tuberculosis (TB)

Studies include:

  • HIV PrEP among people with TB in Uganda (TB PrEP, Ross, PI)
  • New pathways to prevention from community TB screening in South Africa (ThiPhiSA Study, Shapiro, PI)

Read more

STI Prevention

Studies include:

  • Bexsero meningococcal B vaccine for GC prevention among South African women (Biyela study, Celum PI)
  • Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected persons (DoxyPEP and DoxyImpact studies, Celum, PI) 

Read more

POC Diagnostics

Content to be determined

Read more

One Health

Studies include:

  • Disease transmission along complex human-animal networks: a novel method for improving zoonotic disease modeling (CHAIN Study, Meisner, PI)
  • US-Israel Collab: A structural and multiepistemic approach to modeling Brucella transmission along complex networks in Bedouin communities (BRUCE Study, Meisner, PI)

Read more

Refugee Health

Studies include:

  • Head StART Study (O’Laughlin, PI)

Read more

Molecular Mechanisms for Susceptibility to HIV

Studies include:

  • The push and pull of inflammation on HIV susceptibility: impact of host variation in CD101 and AXL (Push/Pull Study, Lingappa, PI)

Read more

Content to be determined